Rifamycin sodium structure
|
Common Name | Rifamycin sodium | ||
---|---|---|---|---|
CAS Number | 14897-39-3 | Molecular Weight | 719.750 | |
Density | 1.35g/cm3 | Boiling Point | 862.1ºC at 760mmHg | |
Molecular Formula | C37H46NNaO12 | Melting Point | >215°C (dec.) | |
MSDS | Chinese USA | Flash Point | 475.2ºC |
Use of Rifamycin sodiumRifamycin sodium (Rifamycin SV monosodium) belongs to the family of ansamycin antibiotics and has been isolated from the fermentation of A. mediterranei or its mutants. Rifamycin sodium displays a broad spectrum of antibiotic activity against Gram-positive and, to a lesser extent, Gram-negative bacteria[1]. |
Name | Rifamycin sodium salt |
---|---|
Synonym | More Synonyms |
Description | Rifamycin sodium (Rifamycin SV monosodium) belongs to the family of ansamycin antibiotics and has been isolated from the fermentation of A. mediterranei or its mutants. Rifamycin sodium displays a broad spectrum of antibiotic activity against Gram-positive and, to a lesser extent, Gram-negative bacteria[1]. |
---|---|
Related Catalog | |
References |
Density | 1.35g/cm3 |
---|---|
Boiling Point | 862.1ºC at 760mmHg |
Melting Point | >215°C (dec.) |
Molecular Formula | C37H46NNaO12 |
Molecular Weight | 719.750 |
Flash Point | 475.2ºC |
Exact Mass | 719.291748 |
PSA | 204.14000 |
LogP | 5.18780 |
Storage condition | -20°C Freezer |
Water Solubility | ethanol: soluble50mg/mL | Soluble in water, alcohol and dimethyl sulfoxide. |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | F |
Safety Phrases | S22-S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | KD1922500 |
HS Code | 2941903000 |
HS Code | 2941903000 |
---|
Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition.
Nat. Prod. Rep. 31(4) , 504-13, (2014) Despite the longstanding importance of polyketide natural products in human medicine, nearly all commercial polyketide-based drugs are prepared through fermentation or semi-synthesis. The paucity of m... |
|
No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients.
AIDS 27(3) , 481-4, (2013) Rifabutin has been substituted for rifampicin when treating tuberculosis (TB)/HIV coinfection. However, despite reports of anti-TB treatment failure and acquired rifamycin resistance, long-term clinic... |
|
Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro.
J. Enzyme Inhib. Med. Chem. 25(5) , 715-9, (2010) Serum paraoxonase (aryldialkylphosphatase, EC 3.1.8.1., PON1) is an esterase protein synthesised by the liver and released into the serum, where it is associated with HDL lipoproteins. In this study, ... |
Rifamycin SV sodium salt |
EINECS 238-965-7 |
Rifamycin SV Monosodium |
MFCD00056847 |
Rifampicin SV sodium |
Rifamycin SV hexahydrate sodium salt |
Rifamycin sodium |
2,7-(Epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, sodium salt, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)- (1:1) |
RIFAMYCIN SV SODIUM SALT HEXAHYDRATE |
RifaMycin SV MonosodiuM salt |
RIFAMYCIN SV-SODIUM |
monosodium rifamycin SV |
RIFAMYCIN,MONOSODIUMSALT |
5,6,9,17,19,21-Hexahydroxy-23-Methoxy-2,4,12,16,18,20,22-heptaMethyl |
Sodium (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetoxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1.0]triacon ta-1(28),2,4,9,19,21,25(29),26-octaen-27-olate |